Home Cart Sign in  
Chemical Structure| 16009-13-5 Chemical Structure| 16009-13-5

Structure of Hemin
CAS No.: 16009-13-5

Chemical Structure| 16009-13-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hemin, an iron-containing porphyrin, acts as an inducer of Heme oxygenase (HO)-1.

Synonyms: Hemin chloride; protohemin; Chloro(protoporphyrinato)iron(III), Chlorohemin, Chloroprotoporphyrin IX iron(III), Ferriprotoporphyrin IX chloride, Hemin(chloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hemin

CAS No. :16009-13-5
Formula : C34H32ClFeN4O4
M.W : 651.94
SMILES Code : [Cl-][Fe+3]123[N-]4C5=C(CCC([O-])=O)C(C)=C4C=C(C(C=C)=C6C)[N]1=C6C=C(C(C=C)=C7C)[N-]2C7=CC(C(C)=C8CCC([O-])=O)=[N]3C8=C5.[H+].[H+]
Synonyms :
Hemin chloride; protohemin; Chloro(protoporphyrinato)iron(III), Chlorohemin, Chloroprotoporphyrin IX iron(III), Ferriprotoporphyrin IX chloride, Hemin(chloride)
MDL No. :MFCD00010726
InChI Key :BTIJJDXEELBZFS-UHFFFAOYSA-K
Pubchem ID :455658

Safety of Hemin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01817530 Heavy Uterine Bleeding ... More >> Uterine Fibroids Less << Phase 2 Completed - -
NCT03086681 Cervical Carcinoma Phase 3 Not yet recruiting February 2020 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Yong Zhang, M.D.    0086-13607884001    zhangyonggx@163.com    Contact: Fang Wu, M.D.          Sub-Investigator: Jian Li, M.D.          Sub-Investigator: Hemin Lu, M.D.          Sub-Investigator: Haixin Huang, Master          Sub-Investigator: Zhanxiong Luo, Master          Sub-Investigator: Meilian Liu, Master          Sub-Investigator: Gaojuan Lin, Master          Sub-Investigator: Sihui Liao, bachelor          Sub-Investigator: Hongqian Wang, bachelor Less <<
NCT00307801 Metrorrhagia Phase 3 Completed - -
NCT00293059 Metrorrhagia Phase 3 Completed - -
NCT00307801 - Completed - -
NCT03338816 Acute Hepatic Porphyria ... More >> Acute Intermittent Porphyria Porphyria, Acute Intermittent Acute Porphyria Hereditary Coproporphyria (HCP) Variegate Porphyria (VP) ALA Dehydratase Deficient Porphyria (ADP) Less << Phase 3 Active, not recruiting September 2021 -
NCT02949830 Acute Intermittent Porphyria Phase 1 Phase 2 Active, not recruiting August 2020 United States, California ... More >> Clinical Trial Site San Francisco, California, United States United States, New York Clinical Trial Site New York, New York, United States United States, Texas Clinical Trial Site Galveston, Texas, United States Sweden Clinical Trial Site Stockholm, Sweden United Kingdom Clinical Trial Site London, United Kingdom Less <<
NCT00293059 - Completed - -
NCT02082860 Acute Intermittent Porphyria Phase 1 Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 12 Octubre Hospital Madrid, Spain, 28041 Less <<
NCT01504308 Uterine Fibroids Phase 2 Phase 3 Terminated(It was not possible... More >> to enroll patients into the study in a realistic timeframe.) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, Oregon Oregon Science and Health University Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt Medical Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 St. Luke's Episcopal Hospital Houston, Texas, United States, 77030 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01735812 Symptomatic Uterine Fibroids Not Applicable Unknown - Israel ... More >> Assaf Harofe Recruiting Zrifin, Israel, 70300 Contact: Moty Pansky, Prof.          Principal Investigator: Moty Pansky, Prof Less <<
NCT02985541 Contraception Phase 3 Active, not recruiting June 4, 2021 -
NCT02654054 Uterine Fibroids ... More >> Heavy Menstrual Bleeding Less << Phase 3 Active, not recruiting December 19, 2018 -
NCT02794467 Adenomyosis Phase 2 Withdrawn(Study was prematurel... More >>y discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.) Less << October 2016 United States, District of Col... More >>umbia GSK Investigational Site Washington, DC, District of Columbia, United States, 20036 United States, Florida GSK Investigational Site West Palm Beach, Florida, United States, 33409 United States, Illinois GSK Investigational Site Champaign, Illinois, United States, 61820 United States, Louisiana GSK Investigational Site Mandeville, Louisiana, United States, 70471 GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Nebraska GSK Investigational Site Lincoln, Nebraska, United States, 68510 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89128 United States, New Jersey GSK Investigational Site Lawrenceville, New Jersey, United States, 08648 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27713 GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Ohio GSK Investigational Site Englewood, Ohio, United States, 45322 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15206 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Less <<
NCT01569763 Menorrhagia Not Applicable Completed - United States, Arizona ... More >> New Horizons Women's Care Chandler, Arizona, United States, 85224 Women's Health Research Phoenix, Arizona, United States, 85015 United States, Indiana Basinski, LLC Newburgh, Indiana, United States, 47630 United States, Kansas Cypress Medical Research Center, LLC Wichita, Kansas, United States, 67226 United States, Minnesota Minnesota Gynecology and Surgery Edina, Minnesota, United States, 55435 United States, Missouri Mercy Clinic Minimally Invasive Gynecology Saint Louis, Missouri, United States, 63141 United States, Tennessee Tennessee Women's Care PC Nashville, Tennessee, United States, 37203 United States, Texas Baylor Research Institute Fort Worth, Texas, United States, 76104 Canada, Ontario McMaster University/Hamilton Health Sciences Hamilton, Ontario, Canada, L8N3Z5 Canada, Quebec Hôpital LaSalle Ville Lassalle, Quebec, Canada, H8P 1C1 Canada, Saskatchewan Regina Qu'Appelle Health Region Regina, Saskatchewan, Canada, S4S 6X3 Canada La Cite Medicale Quebec, Canada, G1W 2J5 Mexico Hospital Universitario, UANL Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT01199159 Hysterectomy Not Applicable Completed - Hong Kong ... More >> University of Hong Kong Hong Kong, Hong Kong Less <<
NCT03271489 Heavy Menstrual Bleeding ... More >> Uterine Fibroids Less << Phase 3 Recruiting May 16, 2022 -
NCT03049735 Heavy Menstrual Bleeding ... More >> Uterine Fibroid Less << Phase 3 Active, not recruiting December 30, 2019 -
NCT03412890 Heavy Menstrual Bleeding ... More >> Uterine Fibroid Less << Phase 3 Enrolling by invitation July 30, 2020 United States, Arizona ... More >> Mesa Mesa, Arizona, United States, 85209 United States, Colorado Denver Denver, Colorado, United States, 80209 United States, Florida Margate Margate, Florida, United States, 33063 United States, Louisiana Metairie Metairie, Louisiana, United States, 70001 United States, Nevada Las Vegas Las Vegas, Nevada, United States, 89128 United States, Ohio Englewood Englewood, Ohio, United States, 45322 United States, Texas Houston Houston, Texas, United States, 77054 Less <<
NCT01675011 - Terminated(Inadequate enrollme... More >>nt) Less << - -
NCT01569763 - Completed - -
NCT01276964 - Unknown September 2012 Italy ... More >> University of L'Aquila Recruiting L'aquila, Italy, 67100 Contact: napolitano       marysanta@libero.it    Principal Investigator: napolitano mariasanta, md          University of Palermo Active, not recruiting Palermo, Italy, 90127 Casa Sollievo Della Sofferenza Irccs Recruiting San Giovanni Rotondo, Italy, 71013 Contact: grandone       grandone@katamail.com    Principal Investigator: elvira grandone, md Less <<
NCT02076763 - Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 12 Octubre Hospital Madrid, Spain, 28041 Less <<
NCT02691494 Uterine Fibroids ... More >> Heavy Menstrual Bleeding Less << Phase 3 Active, not recruiting January 16, 2019 -
NCT01675011 Uterine Fibroids Not Applicable Terminated(Inadequate enrollme... More >>nt) Less << - United States, New York ... More >> Albany Medical Center Albany, New York, United States North Shore LIJ Medical Center New Hyde Park, New York, United States Less <<
NCT01715025 Menorrhagia Phase 4 Unknown August 2015 Australia, New South Wales ... More >> SCRHR Recruiting Sydney, New South Wales, Australia, 2131 Principal Investigator: Edith Weisberg, MB BS MM Less <<
NCT03103087 Heavy Menstrual Bleeding ... More >> Uterine Fibroid Less << Phase 3 Active, not recruiting February 28, 2020 -
NCT03070951 Uterine Fibroids ... More >> Heavy Menstrual Bleeding Less << Phase 3 Recruiting November 2019 -
NCT02925494 Uterine Fibroids ... More >> Heavy Menstrual Bleeding Less << Phase 3 Active, not recruiting April 8, 2019 -
NCT02131662 Leiomyoma Phase 2 Completed - -
NCT03751124 Uterine Leiomyoma ... More >> Uterine Fibroids Less << Phase 3 Enrolling by invitation March 31, 2021 United States, Florida ... More >> United States, Florida West Palm Beach, Florida, United States, 33409 Less <<
NCT02131662 - Completed - -
NCT02935400 Acute Intermittent Porphyria|H... More >>ereditary Coproporphyria|Variegate Porphyria Less << ACTIVE_NOT_RECRUITING 2025-12-31 University of Texas Medical Br... More >>anch, Galveston, Texas, 77555, United States Less <<
NCT02180412 Acute Porphyrias Phase 2 Recruiting August 31, 2020 United States, Texas ... More >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Karl E Anderson, MD    409-772-4661    kanderso@utmb.edu    Contact: Csilla Hallberg, MD    409-772-4661    challberg@utmb.edu    Principal Investigator: Karl E Anderson, MD Less <<
NCT00467610 - Terminated(lack of efficacy.) - -
NCT03070899 Uterine Fibroids ... More >> Heavy Menstrual Bleeding Less << Phase 3 Recruiting February 2020 -
NCT01430156 Graft Failure ... More >> Ischemia-reperfusion Injury Less << Phase 3 Completed - United Kingdom ... More >> Royal Infirmary of Edinburgh/ University of Edinburgh Edinburgh, Lothian, United Kingdom, EH16 4TJ Less <<
NCT01206582 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55901 Less <<
NCT00882804 Healthy Volunteers Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01206582 - Completed - -
NCT01855841 Post-ERCP Acute Pancreatitis Phase 2 Recruiting February 2019 Belgium ... More >> CHU Brugmann Terminated Brussels, Belgium, 1020 Erasme Hospital, Université Libre de Bruxelles (ULB) Recruiting Brussels, Belgium, 1070 Contact: Arnaud Lemmers, MD, PhD    +3225556559    arnaud.lemmers@erasme.ulb.ac.be    Contact: Mohammed Amrani    +3225558382    mohammed.amrani@erasme.ulb.ac.be    Principal Investigator: Arnaud Lemmers, MD, PhD          Sub-Investigator: Olivier Le Moine, MD, PhD          Sub-Investigator: Jacques Devière, MD, PhD          Sub-Investigator: Myriam Delhaye, MD, PhD          Sub-Investigator: Marianna Arvanitakis, MD, PhD          Centre Hospitalier de Jolimont-Lobbes Recruiting Haine-St-Paul, Belgium, 7100 Contact: Didier Verset, MD    +32 478 421 493    didier.verset@skynet.be    Principal Investigator: Didier Verset, MD          CHU Liège Sart Tilman Not yet recruiting Liège, Belgium, 4000 Contact: Jean-Philippe Loly, MD    04/366.74.39    jp.loly@hotmail.com    Contact: Wertz Sylvie    04/366.74.39    swertz@chu.ulg.ac.be    Hôpital Ambroise Paré Recruiting Mons, Belgium, 7000 Contact: Axel Hittelet, MD    065.39.37.48    axel.hittelet@hap.be    Principal Investigator: Axel Hittelet, MD          ISPPC CHU Vésale Terminated Montigny Le tilleul, Belgium, 6110 Italy San Raffaele Scientific Institute, Vita Salute San Raffaele University Not yet recruiting Milan, Italy, 20132 Contact: MariaChiara Petrone, MD       petrone.mariachiara@hsr.it    Principal Investigator: MariaChiara Petrone, MD          Policlinico Gemelli Universita Cattolica Not yet recruiting Rome, Italy, 00168 Contact: Guido Costamagna, MD    06.35511515    gcostamagna@rm.unicatt.it    Principal Investigator: Guido Costamagna, MD          Sub-Investigator: Andrea Tringali, MD          Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Wei-Chih Liao, MD,PhD       david.ntuh@gmail.com    Principal Investigator: Wei-Chih Liao, MD,PhD Less <<
NCT00467610 Myelodysplastic Syndrome Phase 2 Terminated(lack of efficacy.) - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT02922413 Acute Intermittent Porphyria ... More >> Hereditary Coproporphyria Variegate Porphyria Less << Phase 2 Recruiting September 2021 United States, Texas ... More >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Karl E Anderson, MD    409-772-4661    kanderso@utmb.edu    Contact: Csilla Hallberg, MD    409-772-4661 ext 24661    ckhallbe@UTMB.EDU Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.53mL

0.31mL

0.15mL

7.67mL

1.53mL

0.77mL

15.34mL

3.07mL

1.53mL

References

 

Historical Records

Categories